Sfoglia per Autore
Lipoproteine aterogene ed endotelio vascolare
1992 E. Tremoli, S. Colli, P. Maderna, M. Camera, L. Sironi, L. Prati, C. Banfi, L. Mussoni
Effect of triglycerides and triglyceride rich lipoproteins on fibrinolytic system
1993 E. Tremoli, L. Mannucci, L. Sironi, M. Camera, L. Prati, D. Baldassarre, C. Banfi, L. Mussoni
Effects of triglyceride rich lipoproteins on the synthesis of plasminogen activator inhibitor 1 (PAI-1) by HepG2 cells
1993 L. Sironi, L. Mussoni, L. Prati, D. Baldassarre, M. Camera, C. Banfi, E. Tremoli
Triglycerides and the fibrinolytic system
1993 E. Tremoli, L. Sironi, L. Mannucci, L. Prati, M. Camera, C. Banfi, D. Baldassarre, L. Mussoni
Effects of native and modified low density lipoproteins on functional and biochemical aspects of cells involved in the thrombotic process
1993 E. Tremoli, S. Colli, P. Maderna, L. Mannucci, S. Eligini, M. Camera, L. Sironi, M. Sirtori, F. Pazzucconi, L. Prati, D. Baldassarre, C. Banfi, L. Mussoni
Effetto delle VLDL sull'espressione di mRNA per il PAI-1 in cellule HepG2
1994 L. Sironi, L. Mussoni, L. Prati, M. Camera, M. Porta, D. Baldassarre, C. Banfi, E. Tremoli
LDL-acetilate e sintesi di PAI-1 da parte di cellule endoteliali: ruolo del recettore scavenger
1994 L. Mussoni, C. Banfi, D. Baldassarre, L. Prati, E. Tremoli
Triglycerides and the fibrinolytic system
1995 E. Tremoli, L. Sironi, M. Camera, L. Mannucci, L. Prati, C. Banfi, D. Baldassarre, L. Mussoni
REGULATION OF PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 BY ACETYL-LDL IN HUMAN UMBIUCAL VEIN ENDOTIIELIAL CELLS
1995 M. Camera, C. Banfi, L. Mussoni, L. Prati, D. Baldassarre, F. Bernini, E. Tremoli
Effects of protein kinase C inhibitors and of gemfibrozil on the biosynthesis of plasminogen activator inhibitor type 1 by HepG2 cells exposed to very low density lipoproteins
1995 C. Banfi, E. Tremoli, L. Sironi, M. Porta, D. Baldassarre, L. Mussoni
Triglycerides and the fibrinolytic system: in vitro regulation of the synthesis of plasminogen activator type 1 by triglyceride-rich lipoproteins in HepG2 cells
1995 E. Tremoli, L. Sironi, M. Camera, L. Prati, C. Banfi, D. Baldassarre, L. Mussoni
Induzione del PAI-1 da parte di VLDL in cellule HEPG2: meccanismi di trasduzione
1996 C. Banfi, L. Mussoni, D. Baldassarre, E. Tremoli
Signaling pathways involved in the induction of PAI-1 by VLDL in HEPG2 cells
1996 C. Banfi, L. Mussoni, C. Quaglia, D. Baldassarre, E. Tremoli
Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL
1996 L. Sironi, L. Mussoni, L. Prati, D. Baldassarre, M. Camera, C. Banfi, E. Tremoli
Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells
1998 L. Nilsson, C. Banfi, U. Diczfalusy, E. Tremoli, A. Hamsten, P. Eriksson
Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells
1999 C. Banfi, L. Mussoni, P. Risè, M.G. Cattaneo, L.M. Vicentini, F. Battaini, C. Galli, E. Tremoli
Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells
2000 L. Mussoni, C. Banfi, L. Sironi, M. Arpaia, E. Tremoli
Transcriptional regulation of plasminogen activator inhibitor type 1 gene by insulin: insights into the signaling pathway
2001 C. Banfi, P. Eriksson, G. Giandomenico, L. Mussoni, L. Sironi, A. Hamsten, E. Tremoli
Oxidized LDLs influence thrombotic response and cyclooxygenase 2
2002 C. Banfi, S. Colli, S. Eligini, L. Mussoni, E. Tremoli
PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms
2002 C. Banfi, L. Mussoni, E. Tremoli
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile